Patients with birdshot chorioretinopathy (BSCR) can experience a delay in diagnosis owing to the challenges of identifying the condition prior to evolution of characteristic choroidal scars. An objective, noninvasive method for detecting early lesions in BSCR might have an effect on preventing vision loss in these patients.
B irdshot chorioretinopathy (BSCR) is a posterior uveitis named for the characteristic oval or linear creamcolored choroidal lesions that appear throughout the fundus. 1, 2 The natural history of untreated disease is progressive vision loss associated with outer retinal atrophy and reduced electroretinogram amplitudes. 3 However, early identification and treatment can sub-stantially improve visual prognosis. 4 Indocyanine green angiography (ICGA) is one of the most sensitive methods for early detection of disease, identifying hypocyanescent lesions that are more numerous than the hypopigmented spots or late choroidal scars seen on fundus examination. 5-9 While ICGA is important for assisting with early diagnosis, a noninvasive imaging modality that provides similar diagnostic information without the risks of ICGA would be an important advance in patient care. 10 In this study, we present a comparison of en face swept-source optical coherence tomography angiography (SS-OCTA) with ICGA in 3 patients and identify choroidal lesions in the Haller layer (HL) that regress with corticosteroid therapy in patients with acute BSCR. Importantly, only lesions identified in acute disease respond to treatment. En face analysis of SS-OCTA is a promising new method for the early detection of choroidal lesions in patients with BSCR.
Methods
Participants were recruited as part of prospective observational protocols approved by institutional review boards at the University of Washington and the University of Bern, Bern, Switzerland.
Patients with a diagnosis of BSCR were recruited for OCTA imaging between August 2017 and October 2017. Written informed consent was obtained, and the tenets of the Declaration of Helsinki and the Health Insurance Portability and Accountability Act of 1996 regulations were followed. Patients were diagnosed as having BSCR after clinical evaluation that included a medical history review, slitlamp and fundus examination, widefield fluorescein angiography (FA) and ICGA (P200DTx; Optos PLC or Heidelberg Spectralis with 102°lens), and a laboratory evaluation positive for histocompatibility leukocyte antigen (HLA)-A29 and negative testing for other infectious or inflammatory etiologies. The SS-OCTAs and SS-OCTs were obtained with PLEX Elite 9000 (Carl Zeiss AG). Widefield images (approximately 100°) were achieved by montaging sixteen 6 × 6-mm or five 12 × 12-mm cubes. All scans contained 500 A-lines × 500 B-scan locations, with 2 repeated B-scans at each fixed location. FastTrac was used during data acquisition. Optical coherence tomography angiography data were generated using an optical microangiography algorithm.
11 Semiautomated segmentation 12 with manual correction was used to define vascular beds. Sum projection method generated en face images. En face slabs 
Key Points
Question Can noninvasive swept-source optical coherence tomography angiography detect deep choroidal inflammatory lesions?
Findings In this case series of 3 patients with birdshot chorioretinopathy, widefield imaging with swept-source optical coherence tomography angiography identified areas of abnormal flow signal, termed flow voids, in the choroid in a pattern similar to indocyanine green angiography. Furthermore, serial en face images obtained at different choroidal depths suggest acute lesions localize to Haller layer, while chronic lesions may involve the entire choroid.
Meaning En face analysis of widefield swept-source optical coherence tomography angiography imaging shows promise as a noninvasive method for detecting and monitoring choroidal inflammatory diseases such as birdshot chorioretinopathy.
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Use of En Face Swept-Source Optical Coherence Tomography Angiography in Identifying Choroidal Flow Voids but extend to involve the entire choroid in advanced disease. Additionally, lesions appear to lie in close approximation with large choroidal vessels in HL, suggesting they and the surrounding stroma are the primary targets of the disease. 13 Together, our data raise the possibility that the earliest lesions in BSCR are localized in the deep choroid, may regress with therapy, and that without treatment, the damage expands anteriorly into the superficial choroid and ultimately affects the RPE and retina. One question raised by our data regards the nature of the choroidal flow voids identified by SS-OCTA. Do they represent areas of choroidal ischemia or some other change in the optical properties of the choroid owing to the influx of inflammatory cells? In chronic disease, flow voids likely represent a true perfusion abnormality caused by choroidal vascular destruction as a result of untreated inflammation. Conversely, in acute disease, we would hypothesize that flow voids are more likely a result of the change in the tissue's optical properties imparted by the presence of inflammatory cells. However, in the absence of association with the criterion standard of histology, it will be difficult to prove what these flow voids truly represent.
Limitations
Limitations of this study include that these flow voids have only been identified in 3 patients to our knowledge to date, and an unmasked comparison and direct correlation of all lesions identified by ICGA and SS-OCTA was not performed. Additional studies including more patients will likely help clarify the nature of these flow voids, determine the ability of the different imaging modalities to distinguish between acute and chronic lesions, and establish the effect the different lesions have on visual prognosis.
Conclusions
The SS-OCTA can identify choroidal lesions in patients with early BSCR noninvasively. Importantly, en face images of HL can detect lesions that are not visible on fundus examination and were previously only identifiable with ICGA.
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Widefield SS-OCTA and en face image analysis is a new tool that shows potential for use in the diagnosis and monitoring of patients with choroidal inflammatory disease. 
